Bloomberg: Carcinogens Have Infiltrated the Generic Drug Supply in the U.S.
An FDA quality-control nightmare reveals how impurities end up in America’s blood pressure pills.
Read the full article here.
Original story: https://www.bloomberg.com/news/features/2019-09-12/how-carcinogen-tainted-generic-drug-valsartan-got-past-the-fda
Subscribe to Redica Insights
Get quality and compliance insights from our experts in your inbox